1.
Adv Mater
; 27(31): 4611-5, 2015 Aug 19.
Artículo
en Inglés
| MEDLINE
| ID: mdl-26178920
RESUMEN
An enzyme-responsive, paclitaxel-loaded nanoparticle is described and assessed in vivo in a human fibrosarcoma murine xenograft. This work represents a proof-of-concept study demonstrating the utility of enzyme-responsive nanoscale drug carriers capable of targeted accumulation and retention in tumor tissue in response to overexpressed endogenous enzymes.